Quarterly report pursuant to Section 13 or 15(d)

Loss Per Common Share (Tables)

v3.7.0.1
Loss Per Common Share (Tables)
 9 Months Ended
Mar. 31, 2017
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]
The following table summarizes the components of the loss per common share calculation (in thousands, except per share amounts):
 
 
 
Three Months ended
 
Nine Months ended
 
 
 
March 31,
 
March 31,
 
 
 
2017
 
2016
 
2017
 
2016
 
Basic and diluted numerator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net loss attributable to iBio, Inc.
 
$
(3,913)
 
$
(3,036)
 
$
(10,203)
 
$
(7,087)
 
Preferred stock dividends
 
 
26
 
 
-
 
 
26
 
 
-
 
Net loss available to iBio, Inc. stockholders
 
$
(3,939)
 
$
(3,036)
 
$
(10,229)
 
$
(7,087)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Basic and diluted denominator:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
 
89,109
 
 
81,158
 
 
89,109
 
 
78,587
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Per share amount
 
$
(0.04)
 
$
(0.04)
 
$
(0.11)
 
$
(0.09)